Poseida Therapeutics, Inc. (PSTX)
Total Valuation
PSTX has a market cap or net worth of $167.11 million. The enterprise value is $76.82 million.
| Market Cap | 167.11M |
| Enterprise Value | 76.82M |
Important Dates
The next earnings date is Thursday, August 11, 2022, before market open.
| Estimated Earnings Date | Aug 11, 2022 |
| Ex-Dividend Date | n/a |
Share Statistics
PSTX has 62.70 million shares outstanding. The number of shares has increased by 0.93% in one year.
| Shares Outstanding | 62.70M |
| Shares Change (YoY) | +0.93% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 40.83% |
| Owned by Institutions (%) | 43.42% |
| Float | 32.64M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.11 |
| PB Ratio | 1.61 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.35 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.34, with a Debt / Equity ratio of 0.90.
| Current Ratio | 4.34 |
| Quick Ratio | 4.18 |
| Debt / Equity | 0.90 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
Financial Efficiency
Return on equity (ROE) is -97.00%, which is considered low. The company has a ROIC of -143.50%.
| Return on Equity (ROE) | -97.00% |
| Return on Assets (ROA) | -53.70% |
| Return on Capital (ROIC) | -143.50% |
| Revenue Per Employee | $115,452 |
| Profits Per Employee | -$511,367 |
| Employee Count | 283 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.79% in the last 52 weeks.
| Beta (1Y) | n/a |
| 52-Week Price Change | -68.79% |
| 50-Day Moving Average | 2.22 |
| 200-Day Moving Average | 3.85 |
| Average Volume (30 Days) | 254,055 |
Short Selling Information
The latest short interest is 1.94 million, so 3.09% of the outstanding shares have been sold short.
| Short Interest | 1.94M |
| Short % of Shares Out | 3.09% |
| Short % of Float | 5.93% |
| Short Ratio (days to cover) | 12.59 |
Income Statement
In the last 12 months, PSTX had revenue of $32.67 million and -144.72 million in losses. Earnings per share was -$2.32.
| Revenue | 32.67M |
| Gross Profit | 32.67M |
| Operating Income | -160.91M |
| Net Income | -144.72M |
| EBITDA | -136.43M |
| EBIT | -141.12M |
| Earnings Per Share (EPS) | -$2.32 |
Balance Sheet
The company has $183.49 million in cash and $93.20 million in debt, giving a net cash position of $90.29 million or $1.44 per share.
| Cash & Cash Equivalents | 183.49M |
| Total Debt | 93.20M |
| Net Cash | 90.29M |
| Net Cash Per Share | $1.44 |
| Book Value | 103.70M |
| Book Value Per Share | 1.65 |
| Working Capital | 146.59M |
Cash Flow
In the last 12 months, operating cash flow was -$114.81 million and capital expenditures -$2.88 million, giving a free cash flow of -$117.70 million.
| Operating Cash Flow | -114.81M |
| Capital Expenditures | -2.88M |
| Free Cash Flow | -117.70M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -492.48% and -442.93%.
| Gross Margin | 100.00% |
| Operating Margin | -492.48% |
| Pretax Margin | n/a |
| Profit Margin | -442.93% |
| EBITDA Margin | -417.57% |
| EBIT Margin | -431.92% |
| FCF Margin | -360.22% |
Dividends & Yields
PSTX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Earnings Yield | -86.60% |
| FCF Yield | -70.43% |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.93% |
| Shareholder Yield | -0.93% |
Analyst Forecast
The average price target for PSTX is $16.58, which is 522.14% higher than the current price. The consensus rating is "Buy".
| Price Target | $16.58 |
| Price Target Difference | 522.14% |
| Analyst Consensus | Buy |
| Analyst Count | 11 |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |